Return to homepagePandemic Pact

EBO-BOOST-BRIDGE: Cross-reactive antibody responses to Bundibugyo virus

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:0 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    Ebola, Marburg virus disease

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $1,020,000

  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)

  • Principal Investigator

    Wim Adriaensen

  • Research Location

    Congo (DRC)

  • Lead Research Institution

    Institute of Tropical Medicine Antwerp

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

EBO-BOOST-BRIDGE will test antibody responses across orthoebolaviruses and Marburg virus, prioritising whether immune responses generated by existing Ebola vaccines recognise Bundibugyo virus.